BEDAIR Trademark

Trademark Overview

On Thursday, March 12, 2009, a trademark application was filed for BEDAIR with the United States Patent and Trademark Office. The USPTO has given the BEDAIR trademark a serial number of 77689467. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 22, 2012. This trademark is owned by Glaxo Group Limited. The BEDAIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
bedair

General Information

Serial Number77689467
Word MarkBEDAIR
Filing DateThursday, March 12, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 22, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 16, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, October 22, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 22, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 24, 2012EXTENSION 5 GRANTED
Monday, March 12, 2012EXTENSION 5 FILED
Monday, March 12, 2012TEAS EXTENSION RECEIVED
Wednesday, August 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 16, 2011EXTENSION 4 GRANTED
Wednesday, August 10, 2011EXTENSION 4 FILED
Wednesday, August 10, 2011TEAS EXTENSION RECEIVED
Saturday, February 19, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 18, 2011EXTENSION 3 GRANTED
Monday, February 14, 2011EXTENSION 3 FILED
Monday, February 14, 2011TEAS EXTENSION RECEIVED
Thursday, September 16, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 15, 2010EXTENSION 2 GRANTED
Friday, August 20, 2010EXTENSION 2 FILED
Wednesday, September 15, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 20, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 16, 2010EXTENSION 1 GRANTED
Tuesday, February 16, 2010EXTENSION 1 FILED
Tuesday, February 16, 2010TEAS EXTENSION RECEIVED
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 22, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 30, 2009PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2009NOTICE OF PUBLICATION
Saturday, May 23, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, May 23, 2009ASSIGNED TO LIE
Friday, May 22, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 14, 2009ASSIGNED TO EXAMINER
Monday, March 16, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 16, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

bedair pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic